Published in World J Gastroenterol on November 14, 2013
Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol (2014) 0.96
The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. World J Surg (2015) 0.79
Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma. BMC Cancer (2016) 0.75
Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI. BMC Med Imaging (2016) 0.75
Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article. Medicine (Baltimore) (2017) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer (1954) 12.77
MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology (2008) 2.19
Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology (2007) 1.61
Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol (2009) 1.36
Mechanisms of human hepatocarcinogenesis. Curr Mol Med (2003) 1.35
Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology (1997) 1.31
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol (2010) 1.31
Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver (1999) 1.29
Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol (2009) 1.17
Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl (2004) 1.14
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol (2011) 1.13
The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol (2001) 1.08
Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology (1989) 1.05
Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol (2003) 1.04
Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology (2011) 1.03
Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol (2007) 1.03
Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am (2007) 1.02
Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol (2006) 1.01
Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis (2010) 1.01
The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol (2010) 1.00
Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging (2010) 0.93
Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdom Imaging (2011) 0.90
Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology (2005) 0.90
Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography. Br J Radiol (2006) 0.87
Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. AJR Am J Roentgenol (2011) 0.82
Serial hemodynamic measurements in well-differentiated hepatocellular carcinomas. Hepatology (1995) 0.81
Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. J Magn Reson Imaging (2006) 0.80
Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol (2007) 0.79
Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound. Anticancer Res (2011) 0.78
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A (2007) 11.85
Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res (2005) 2.58
Type II collagen gene variants and inherited osteonecrosis of the femoral head. N Engl J Med (2005) 2.08
Novel point mutations in complete androgen insensitivity syndrome with incomplete müllerian regression: two Taiwanese patients. Eur J Pediatr (2003) 1.65
Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI: in comparison with compression fracture and metastasis. J Magn Reson Imaging (2002) 1.57
Outcomes of hepatectomy for hepatolithiasis. World J Surg (2007) 1.54
Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging (2008) 1.47
Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene (2003) 1.43
Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity. Int J Radiat Biol (2013) 1.42
Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum. Anal Chem (2011) 1.42
A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression. Cancer Cell (2011) 1.40
Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res (2010) 1.39
Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog (2010) 1.27
Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology (2007) 1.23
Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan. PLoS One (2013) 1.21
Open lung biopsy in early-stage acute respiratory distress syndrome. Crit Care (2006) 1.20
Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications. Cancer (2008) 1.16
Gallbladder torsion: preoperative diagnosis by MDCT. Abdom Imaging (2007) 1.15
Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. Int J Cancer (2009) 1.12
Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J (2007) 1.09
Fulminant pulmonary calciphylaxis and metastatic calcification causing acute respiratory failure in a uremic patient. Am J Kidney Dis (2006) 1.07
Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Chang Gung Med J (2004) 1.06
Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer. Lung Cancer (2006) 1.05
Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications. J Cancer Res Clin Oncol (2009) 1.03
Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res (2010) 1.02
Spontaneous regression of hepatocellular carcinoma: a case report and literature review. Hepatogastroenterology (2004) 1.01
RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer (2006) 0.99
Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Colon Rectum (2004) 0.99
Characterization of neuroblastic tumors using 18F-FDOPA PET. J Nucl Med (2012) 0.97
Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan. J Thorac Oncol (2010) 0.94
Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma. Mol Med (2012) 0.94
Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53. Biochem Pharmacol (2011) 0.94
Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharm (2011) 0.93
High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene (2005) 0.93
Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis. Mol Med (2012) 0.92
The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol (2009) 0.92
Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer. Lung Cancer (2007) 0.92
Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. Lab Invest (2005) 0.91
Clinical implications of high MET gene dosage in non-small cell lung cancer patients without previous tyrosine kinase inhibitor treatment. J Thorac Oncol (2011) 0.90
Imaging differentiation of phytobezoar and small-bowel faeces: CT characteristics with quantitative analysis in patients with small- bowel obstruction. Eur Radiol (2014) 0.89
Plasma nuclear DNA and mitochondrial DNA as prognostic markers in corrosive injury patients. Dig Surg (2008) 0.89
Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis. Gene Expr (2006) 0.89
Severe intrahepatic cholestasis in an elderly patient with primary amyloidosis and colon adenocarcinoma. Chang Gung Med J (2004) 0.88
Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res (2009) 0.88
Diabetes worsens the surgical outcomes in cirrhotic patients with hepatocellular carcinoma. Tohoku J Exp Med (2012) 0.88
Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther (2009) 0.87
Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity. Mol Cancer Res (2009) 0.87
MRI of angiomatoid fibrous histiocytoma. Skeletal Radiol (2004) 0.86
Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy. Antivir Ther (2009) 0.86
Malignant phyllodes tumor of the prostate. Int J Urol (2005) 0.86
Factors affecting prognosis of small hepatocellular carcinoma in Taiwanese patients following hepatic resection. Can J Gastroenterol (2011) 0.86
Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. World J Gastroenterol (2006) 0.86
The use of ASCs engineered to express BMP2 or TGF-β3 within scaffold constructs to promote calvarial bone repair. Biomaterials (2013) 0.86
Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections. Hum Pathol (2004) 0.86
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol (2013) 0.86
Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo. Mol Med Rep (2011) 0.85
Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. Hum Pathol (2004) 0.85
Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging. J Magn Reson Imaging (2010) 0.85
Acute respiratory distress syndrome caused by leukemic infiltration of the lung. J Formos Med Assoc (2008) 0.85
Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck (2011) 0.84
Localized surface plasmon coupled fluorescence fiber-optic biosensor for alpha-fetoprotein detection in human serum. Biosens Bioelectron (2008) 0.84
Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer. Oncol Rep (2011) 0.84
Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. Int J Cancer (2014) 0.84
Solitary primary tracheal small-cell lung cancer causing acute respiratory failure: diagnosis and treatment. Respir Care (2010) 0.84
Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance. Cell Transplant (2008) 0.84
Contrast-enhanced ultrasonography of hepatic metastasis of hemangiopericytoma. J Ultrasound Med (2008) 0.84
Ultrasound biomicroscopy in pigmented conjunctival cystic nevi. Cornea (2004) 0.83
Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma. Cancer Res (2012) 0.83
Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer. Anticancer Res (2005) 0.83
Evaluation of the Chinese Medicinal Herb, Graptopetalum paraguayense, as a Therapeutic Treatment for Liver Damage in Rat Models. Evid Based Complement Alternat Med (2012) 0.83
Relationship between vertebral bone marrow blood perfusion and common carotid intima-media thickness in aging adults. J Magn Reson Imaging (2004) 0.83
Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection. J Formos Med Assoc (2003) 0.83
Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma. Ann Surg Oncol (2013) 0.83
Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System. Cancer Inform (2012) 0.83
Hepatic hydatid cysts with superinfection in a non-endemic area in Taiwan. Am J Trop Med Hyg (2002) 0.83
Fish fin aspiration: an unusual type of lower airway foreign body in a Chinese adult. Respir Care (2013) 0.83
Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis. Scand J Gastroenterol (2008) 0.83
The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network. Medicine (Baltimore) (2016) 0.83
Presence of fibrosis is predictive of postoperative survival in patients with small hepatocellular carcinoma. Hepatogastroenterology (2015) 0.83
Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images. Abdom Imaging (2014) 0.82
Co-existence of a huge pseudocyst and mucinous cystadenoma: report of a case and the value of magnetic resonance imaging for differential diagnosis. Eur J Gastroenterol Hepatol (2002) 0.82
Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer. J Biol Chem (2011) 0.82
Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia. J Neuroimmunol (2010) 0.82
Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases. J Formos Med Assoc (2002) 0.82
Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol (2007) 0.82
Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver. Proteomics Clin Appl (2010) 0.82
Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning. Ultrasound Med Biol (2013) 0.81
Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice. Int J Cancer (2011) 0.81
Innovative technique for preventing hepatic artery kinking in living donor liver transplantation. Liver Transpl (2013) 0.81
Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol (2014) 0.81
Immune responses during healing of massive segmental femoral bone defects mediated by hybrid baculovirus-engineered ASCs. Biomaterials (2012) 0.81
Pseudomyxoma peritonei, origin from appendix: report of cases with images. Int Surg (2003) 0.81
Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats. J Hepatol (2004) 0.81